A 55 year old female with HYPOGLYCEMIA under evaluation, DM + since 10 years,? DENOVO HTN
This is an online E log book to discuss our patient's de-identified health data shared after taking his/her/guardian's signed informed consent. Here we discuss our individual patient's problems through series of inputs from global online community of experts with an aim to solve those patient's clinical problems with collective current best evidence based inputs. This E log book also reflects my patient-centred online learning portfolio and your valuable inputs on the comment box is welcome."I've been given this case to solve in an attempt to understand the topic of "patient clinical data analysis" to develop my competency in reading and comprehending clinical data including history, clinical findings, investigations and come up with a diagnosis and treatment plan
CHIEF COMPLAINTS
A 55 year old female was brought to casualty at 1:00 am in the night on 26/12/2021 with
C/o sudden unresponsiveness since 1 hour.
C/o Generalised swelling & abdominal distension since 10 days.
HOPI: Patient was apparently asymptomatic 1 hour back.She took her inj.Human Mixtard 23U and had her dinner and slept,later patients attenders observed that she was snoring and sweating excessively and tried to wake her up,but she was unresponsive,then they checked her GRBS which was 35 mg/dl.
No H/o seizures, head trauma, headache
No c/o decreased urine output,fever.
No c/o orthopnea,PND
PAST HISTORY
K/c/o DM and is on Inj.Human Mixtard
34U-------X-------23U
DENOVO HTN ,used medication for 2 days and stopped.
Not a k/c/o TB, Epilepsy, Asthma,CAD
PERSONAL HISTORY
DIET: Mixed
APPETITE: Normal
B&B: Regular
ADDICTIONS: No addictions
FAMILY HISTORY- Not significant.
GENERAL EXAMINATION
No Pallor
No Icterus
No Clubbing
No Lymphadenopathy.
No Edema
Vitals:
BP: 130/90 mm hg
PR: 56 BPM
Temp: 98 F
Spo2: 98% @ RA
GRBS: 34 mg/ dl
SYSTEMIC EXAMINATION.
CVS: S1 S2 +, NO MURMURS
RS: BAE+, NVBS
P/A: SOFT, DISTENDED , BS+
CNS: GCS- E1 V1 M1, pupils reactive
Patient was given IVF 25% D after which patient is C/C/C, Oriented to time,place and person.
R. L.
POWER. Normal. Normal.
TONE Normal. Normal.
INVESTIGATIONS
PLAN OF TREATMENT
GRBS Monitoring hourly.
Inl.HUMAN ACTRAPID SC acc to GRBS TID. I/O Charting.
Tab.LASIX 40 mg PO BD.
Tab.AMLONG 5 mg PO OD.
